Firazorexton |
Firazorexton : Agonist of HCRTR2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| HCRTR2 |
|
|
Agonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
More than 700-fold OX2R selectivity over OX1R (calcium mobilization using hOX1R/CHO-K1 cells was 14, ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
Selectivity vs hOX1R was assessed in CHO-K1 cells showing EC50 14000 nM
Potency Cellular
In Vitro
HCRTR2
Mode of Action: Agonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1124/jpet.122.001449
In Vivo Validations
Mouse
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
1.10 h (MRT)
Cmax:
2221.5 ng/mL
Tmax:
0.5 h
Area Under the Curve::
2575.0 ng*h/mL
DOI Reference: 10.1124/jpet.122.001449
Dose: 30 mg/Kg
Route of delivery:
Oral
Plasma half life:
1.06 h (MRT)
Cmax:
5966.4 ng/mL
Tmax:
0.5 h
Area Under the Curve::
6867.7 ng*h/mL
DOI Reference: 10.1124/jpet.122.001449
Dose: 3 mg/Kg
Route of delivery:
Oral
Plasma half life:
0.94 h (MRT)
Cmax:
967.5 ng/mL
Tmax:
0.5 h
Area Under the Curve::
1106.0 ng*h/mL
DOI Reference: 10.1124/jpet.122.001449
Chemical Information
| Molecular Formula | C22H25F3N2O4S |
| SMILEs | CC(C)(O)C(=O)N1CC[C@H](NS(C)(=O)=O)[C@@H]1Cc1cccc(-c2cc(F)cc(F)c2)c1F |
| InChI | InChI=1S/C22H25F3N2O4S/c1-22(2,29)21(28)27-8-7-18(26-32(3,30)31)19(27)11-13-5-4-6-17(20(13)25)14-9-15(23)12-16(24)10-14/h4-6,9-10,12,18-19,26,29H,7-8,11H2,1-3H3/t18-,19-/m0/s1 |
| Molecular weight | 470.15 Da |
| AlogP | 0.0 |
| HBond acceptors | 6 |
| HBond donors | 2 |
| Atoms | 57 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.